Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $214K 1,600 sh |
| Jan 15, 2026 traded Jan 14, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $174K 1,286 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 6 | Prober Charles J.Director | Option exercise · 10b5-1 plan | M | $89K 7,930 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 6 | Cooper Jeffrey ElliottChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $39K 216 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $99K 8,318 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $129K 10.9K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 5 | Truong KristinaChief Accounting Officer | Tax withholding | F | $8,662 1,080 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 5 | Morris DonnaExecutive Vice President | Tax withholding · 10b5-1 plan | F | $619K 5,250 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 5 | Halm JillianChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $4,995 379 sh | Jan 15, 2026 traded Jan 15, 2026 |
| 5 | Shah ShardulDirector | Open-market sale · 10b5-1 plan | SELL | $25K 200 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 5 | Furner John R.Executive Vice President | Grant or award | A | — 23.8K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 4 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 4 | Nguyen DianeEVP, Chief Legal Officer & GC | Open-market sale · 10b5-1 plan | SELL | $127K 4,519 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 4 | Dines DanielDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $692K 45.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 4 | Merriman Dwight ADirector | Open-market sale · 10b5-1 plan | SELL | $81K 200 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 4 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 4 | Merriman Dwight ADirector | Open-market sale · 10b5-1 plan | SELL | $139K 340 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 4 | Merriman Dwight ADirector | Open-market sale · 10b5-1 plan | SELL | $442K 1,139 sh | Jan 15, 2026 traded Jan 15, 2026 |
| 3 | Prober Charles J.Director | Option exercise · 10b5-1 plan | M | — 7,930 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $41K 300 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $41K 300 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 2 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $59K 4,167 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 2 | Bentley Sheldon Richard10% Owner, Founder | Open-market sale · 10b5-1 plan | SELL | $21K 25.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 2 | Bentley Sheldon Richard10% Owner, Founder | Open-market sale · 10b5-1 plan | SELL | $22K 25.0K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Sijbrandij SytseDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 54.3K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 4,167 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 0 | Reed Cory JPres, Life Sol Cust Sup & S.M. | Option exercise · 10b5-1 plan | M | — 12.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Morris DonnaExecutive Vice President | Grant or award · 10b5-1 plan | A | — 15.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 3,542 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Sijbrandij SytseDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 54.3K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 51 | Feinberg PeterDirector | Open-market purchase | BUY | $87K 20.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 49 | Hildebrandt John DPresident and COO | Open-market sale | SELL | $1.02M 7,421 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 48 | DiGravio Karen AnnTrustee | Open-market purchase | BUY | $3,062 378 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 46 | Kovaleski PaulEVP-Chief Merch. Officer | Open-market sale | SELL | $582K 4,255 sh | Jan 14, 2026 traded Jan 12, 2026 |